HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Michael Todd, ‘Where Science Meets Nature,’ Meets FDA Warning Letter

This article was originally published in The Rose Sheet

Executive Summary

Port St. Lucie, Fla.-based firm’s Intensive Eye Treatment and Knu Anti-Aging Face Lift Serum are unapproved drugs based on claims featured online, FDA says. The July 18 warning letter, posted to the agency’s website Aug. 16, was one of at least 10 that issued to skin-care companies in July.


Related Content

FDA’s July Warning Letters To Skin-Care Marketers Continue To Surface
FDA Warning Letter Barrage Continues With Five More To Close July





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts